Friday, April 25, 2014 Last update: 2:33 AM
Fast Breaking Live News = 100's of Daily Sales Leads

RBCC to Scout New Innovations at Biotech Showcase

Companies mentioned in this article: Rainbow Coral Corp.

MIRAMAR BEACH, Fla. -- (BUSINESS WIRE) -- Executive leadership from Rainbow Coral Corp. (OTCBB: RBCC), a fast-rising biotechnology company, will scout for new innovations and potential partnerships this month at the sixth annual Biotech Showcase in San Francisco.

Held January 13-15, the Biotech Showcase investor and partnering conference is an established innovation forum for life science investors. Executive-level delegates representing top public and private investment firms come with the single aim to partner with emerging biotechnology and life science companies.

It’s an ideal place for RBCC executives to meet and hear from cutting-edge researchers and developers who could potentially help the company achieve its ambitious goals in the booming global drug delivery and personalized medicine markets.

"There’s no more important industry showcase in the U.S.," said RBCC CEO Kimberly Palmer. "It’s the largest gathering of leading-edge, growth-oriented biotech innovation in the country, and we’re tremendously excited to make new contacts and, potentially, new partnerships at the conference that could help make 2014 our best year yet."

By acquiring or partnering with up-and-coming biotech innovators, RBCC plans to be well-positioned to capitalize on the big growth in store for the industry. The company invests in new technology developed to compete in the biotechnology sector alongside Amgen (NASDAQ: AMGN), Dendreon Corporation (NASDAQ: DNDN), Smith & Nephew (NYSE: SNN) and Pharmaceutical Product Development (NASDAQ: PPDI).

For more information on RBCC’s other biotech initiatives, please visit www.rainbowbiosciences.com.

About Rainbow Biosciences

Rainbow Biosciences, LLC, is a wholly owned subsidiary of Rainbow Coral Corp. (OTCBB: RBCC). The Company continually seeks out new partnerships with biotechnology developers to deliver profitable new medical technologies and innovations. For more information on our growth-oriented business initiatives, please visit www.RainbowBioSciences.com.

Notice Regarding Forward-Looking Statements

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipate" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone's past success, either financial or strategic, is no guarantee of future success. This news release speaks as of the date first set forth above and the Company assumes no responsibility to update the information included herein for events occurring after the date hereof.


Copyright © Business Wire 2014
Contact:

Rainbow Coral Corp.
Kimberly Palmer, 850-269-7230
President and CEO
info@rainbowcoral.com